Back to Search Start Over

Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone

Authors :
Anne-Marie Dupuy
Manuela Lotierzo
Victor Urbain
Jean-Paul Cristol
Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp)
Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)
Source :
Practical Laboratory Medicine, Practical Laboratory Medicine, Elsevier, 2021, 25, pp.e00220. ⟨10.1016/j.plabm.2021.e00220⟩, Practical Laboratory Medicine, Vol 25, Iss, Pp e00220-(2021)
Publication Year :
2021
Publisher :
Elsevier, 2021.

Abstract

Objectives A newly developed fully automated Lumipulse G AMH method (Fujirebio Diagnostics) was recently introduced in clinical laboratories for quantitative determination of anti-Mullerian hormone (AMH) level in human serum or plasma. AMH has emerged as value-added biomarker in the assessment of ovarian reserve, in diagnosis of granulosa cells cancer and in the investigation of gonadal disorders. We compared Lumipulse G AMH assay performances with other methods largely applied for AMH measurements. Design and Methods The Lumipulse G AMH method based on two-step sandwich chemiluminescence enzyme immunoassay was assessed on Lumipulse G600II analyzer. The evaluation study included imprecisions, sensitivity and linearity whereas a comparison study was performed on a heterogeneous population of 114 patients by using the Elecsys AMH Plus assay on COBAS 8000 e602 module (Roche Diagnostics). Results Lumipulse G AMH system showed good repeatability (within-run imprecision) with CV values below 1% (0.5% and 0.9% for high and low serum pools). Similarly within-laboratory imprecision was assessed with CV values of 2.5% and 1.6% for high and low level controls respectively. A linearity regression formula of 1.0119x-0.067 with a coefficient of determination (r2) equal to 0.999 was obtained in a range from 0.044 to 22.42 ​ng/ml. Passing-Bablok regression analysis was performed for assay comparability of AMH measurements. Results were closely correlated (correlation coefficient ​= ​0.997) with a regression equation (y ​= ​1.230x-0.025) showing a positive slope. Also, Bland-Altman analysis confirmed a good agreement between Lumipulse G AMH and Roche Elecsys AMH Plus assays with a bias of 17.76% in a large measurement range. Conclusions The performance of Lumipulse G AMH system was highly comparable with that of Roche Elecsys AMH Plus assay although approximately 10% higher values of AMH levels were observed for Lumipulse AMH system at all range of concentrations. Nevertheless the Lumipulse G system seems to be largely suitable for quantitative determination of AMH level in small-scale laboratory because of the reduced size and the use of single cartridge per test assuring flexibility and easy handling.

Details

Language :
English
ISSN :
23525517
Volume :
25
Database :
OpenAIRE
Journal :
Practical Laboratory Medicine
Accession number :
edsair.doi.dedup.....64f641a79ae4ea170591f44f17815f83
Full Text :
https://doi.org/10.1016/j.plabm.2021.e00220⟩